Ditchcarbon
  • Contact
  1. Organizations
  2. F. Hoffmann-La Roche AG
Public Profile
Pharmaceutical Preparation Manufacturing
CH
updated a month ago

F. Hoffmann-La Roche AG Sustainability Profile

Company website

F. Hoffmann-La Roche AG, commonly known as Roche, is a leading global healthcare company headquartered in Basel, Switzerland (CH). Founded in 1896, Roche has established itself as a pioneer in the pharmaceutical and diagnostics industries, focusing on innovative solutions for oncology, immunology, infectious diseases, and personalised medicine. With a strong presence in Europe, North America, and Asia, Roche is renowned for its commitment to research and development, boasting a robust portfolio of core products, including groundbreaking biologics and diagnostic tools. The company’s unique approach to integrating pharmaceuticals and diagnostics sets it apart in the market, enabling tailored treatment options for patients. Roche's notable achievements include being consistently ranked among the top pharmaceutical companies worldwide, reflecting its dedication to advancing healthcare and improving patient outcomes.

DitchCarbon Score

How does F. Hoffmann-La Roche AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

90

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

F. Hoffmann-La Roche AG's score of 90 is higher than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.

93%

Let us know if this data was useful to you

F. Hoffmann-La Roche AG's reported carbon emissions

In 2024, F. Hoffmann-La Roche AG reported total carbon emissions of approximately 5,474,000,000 kg CO2e, with emissions distributed across all three scopes: 245,832,000 kg CO2e (Scope 1), 69,198,000 kg CO2e (Scope 2), and 5,478,525,000 kg CO2e (Scope 3). The Scope 3 emissions are particularly significant, accounting for about 99% of the total emissions, highlighting the importance of addressing upstream and downstream activities in their climate strategy. In 2023, the company recorded total emissions of about 5,978,508,000 kg CO2e, with Scope 1 emissions at 240,266,000 kg CO2e and Scope 2 emissions at 98,480,000 kg CO2e. This indicates a slight reduction in total emissions from the previous year, reflecting ongoing efforts to improve sustainability. F. Hoffmann-La Roche AG has set a mid-term goal to reduce energy consumption from Scope 1 and Scope 2 sources per employee by 15% by 2025, starting from a baseline established in 2015. This commitment demonstrates the company's focus on enhancing energy efficiency within its facilities. The emissions data is cascaded from Roche Holding AG, the parent company, which also influences the climate initiatives and targets set by F. Hoffmann-La Roche AG. The company actively participates in various climate initiatives, although specific SBTi targets were not disclosed. Overall, F. Hoffmann-La Roche AG's emissions profile and reduction commitments reflect a comprehensive approach to tackling climate change, with a strong emphasis on reducing energy consumption and addressing the substantial Scope 3 emissions that dominate their carbon footprint.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201120122013201420152016202220232024
Scope 1
419,306,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
443,583,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
00,000,000
00,000,000
Scope 3
160,632,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
0,000,000,000
0,000,000,000
0,000,000,000

How Carbon Intensive is F. Hoffmann-La Roche AG's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. F. Hoffmann-La Roche AG's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is F. Hoffmann-La Roche AG's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for F. Hoffmann-La Roche AG is in CH, which has a very low grid carbon intensity relative to other regions.

F. Hoffmann-La Roche AG's Scope 3 Categories Breakdown

F. Hoffmann-La Roche AG's Scope 3 emissions, which decreased by 8% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 71% of Scope 3 emissions.

Top Scope 3 Categories

2024
Purchased Goods and Services
71%
Capital Goods
10%
Upstream Transportation & Distribution
5%
End-of-Life Treatment of Sold Products
4%
Use of Sold Products
4%
Business Travel
3%
Fuel and Energy Related Activities
1%
Employee Commuting
1%
Investments
1%
Waste Generated in Operations
<1%

F. Hoffmann-La Roche AG's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

F. Hoffmann-La Roche AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare F. Hoffmann-La Roche AG's Emissions with Industry Peers

Bristol-Myers Squibb

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Par Pharmaceutical

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Vertex Pharmaceuticals

US
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Glenmark Pharmaceuticals

IN
•
Pharmaceutical Preparation Manufacturing
Updated 16 days ago

Genzyme Corporation, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251118.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy